Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators

Toxicology Letters

Volumn 210, Issue 1, 2012, Pages 64-70

  Singh, Thoudam S K ^a   Lee, Soyoung ^a   Kim, Hui Hun ^a   Choi, Jin Kyeong ^a   Kim, Sang Hyun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Allergic inflammation; Calcium; Histamine; Mast cells; Perfluorooctanoic acid

Indexed keywords

CALCIUM; CYCLOOXYGENASE 2; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PERFLUOROOCTANOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVATION; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOTOXICITY; INFLAMMATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CALCIUM; CASPASE 1; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; ENZYME ACTIVATION; FEMALE; FLUOROCARBONS; HISTAMINE RELEASE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; OCTANOIC ACIDS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 84862811441     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.01.014     Document Type: Article

References (42)

1. Arbabi S., Maier R.V. Mitogen-activated protein kinases. Crit. Care Med. 2002, 30:S74-S79.
2. Bae Y., Lee S., Kim S.H. Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-kappaB. Toxicol. Appl. Pharmacol. 2011, 254:56-64.
3. Beaven M.A., Rogers J., Moore J.P., Hesketh T.R., Smith G.A., Metcalfe J.C. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J. Biol. Chem. 1984, 259:7129-7136.
4. Begley T.H., White K., Honigfort P., Twaroski M.L., Neches R., Walker R.A. Perfluorochemicals: potential sources of and migration from food packaging. Food Addit. Contam. 2005, 22:1023-1031.
5. Bochenek G., Nizankowska E., Gielicz A., Swierczynska M., Szczeklik A. Plasma 9alpha, 11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 2004, 59:459-464.
6. Castle J.D., Guo Z., Liu L. Function of the t-SNARE SNAP-23 and secretory carrier membrane proteins (SCAMPs) in exocytosis in mast cells. Mol. Immunol. 2002, 38:1337-1340.
7. Ennis M., Pearce F.L., Weston P.M. Some studies on the release of histamine from mast cells stimulated with polylysine. Br. J. Pharmacol. 1980, 70:329-334.
8. Fairley K.J., Purdy R., Kearns S., Anderson S.E., Meade B.J. Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. Toxicol. Sci. 2007, 97:375-383.
9. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
10. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as tunable effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
11. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
12. 2+ entry and NFAT activation in lymphocytes. Cell Calcium 2007, 42:145-156.
13. Jeong H.J., Hong S.H., Lee D.J., Park J.H., Kim K.S., Kim H.M. Role of Ca(2+) on TNF-alpha and IL-6 secretion from RBL-2H3 mast cells. Cell Signal. 2002, 14:633-639.
14. Kawata R., Reddy S.T., Wolner B., Herschman H.R. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. J. Immunol. 1995, 155:818-825.
15. Kennedy G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., Biegel L.B., Murphy S.R., Farrar D.G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 2004, 34:351-384.
16. Kim S.H., Choi C.H., Kim S.Y., Eun J.S., Shin T.Y. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp. Biol. Med. (Maywood) 2005, 230:82-88.
17. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91:123-131.
18. Kim S.H., Lee S., Kim I.K., Kwon T.K., Moon J.Y., Park W.H., Shin T.Y. Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes. Food Chem. Toxicol. 2007, 45:2138-2144.
19. Kim S.H., Lee S., Suk K., Bark H., Jun C.D., Kim D.K., Choi C.H., Yoshimura T. Discoidin domain receptor 1 mediates collagen-induced nitric oxide production in J774A. 1 murine macrophages. Free Radic. Biol. Med. 2007, 42:343-352.
20. Kim S.H., Sharma R.P. Mercury-induced apoptosis and necrosis in murine macrophages: role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicol. Appl. Pharmacol. 2004, 196:47-57.
21. Kim S.H., Shin T.Y. Amomum xanthiodes inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production. Exp. Biol. Med. (Maywood) 2005, 230:681-687.
22. Ku G., Faust T., Lauffer L.L., Livingston D.J., Harding M.W. Interleukin-1 beta converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 1996, 8:377-386.
23. Kubwabo C., Stewart B., Zhu J., Marro L. Occurrence of perfluorosulfonates and other perfluorochemicals in dust from selected homes in the city of Ottawa, Canada. J. Environ. Monit. 2005, 7:1074-1078.
24. Kudo N., Kawashima Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 2003, 28:49-57.
25. Levi-Schaffer F., Temkin V., Malamud V., Feld S., Zilberman Y. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. J. Immunol. 1998, 160:5554-5562.
26. Lin T.J., Garduno R., Boudreau R.T., Issekutz A.C. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J. Immunol. 2002, 169:4522-4530.
27. Mannino D.M., Homa D.M., Akinbami L.J., Moorman J.E., Gwynn C., Redd S.C. Surveillance for asthma-United States, 1980-1999. MMWR Surveill. Summ. 2002, 51:1-13.
28. McMurdo C.J., Ellis D.A., Webster E., Butler J., Christensen R.D., Reid L.K. Aerosol enrichment of the surfactant PFO and mediation of the water-air transport of gaseous PFOA. Environ. Sci. Technol. 2008, 42:3969-3974.
29. Mican J.A., Arora N., Burd P.R., Metcalfe D.D. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J. Allergy Clin. Immunol. 1992, 90:815-824.
30. Moller A., Henz B.M., Grutzkau A., Lippert U., Aragane Y., Schwarz T., Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 1998, 93:289-295.
31. Park H.H., Lee S., Oh J.M., Lee M.S., Yoon K.H., Park B.H., Kim J.W., Song H., Kim S.H. Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol. Res. 2007, 55:31-37.
32. Paruchuri S., Jiang Y., Feng C., Francis S.A., Plutzky J., Boyce J.A. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. J. Biol. Chem. 2008, 283:16477-16487.
33. Pawliczak R., Logun C., Madara P., Lawrence M., Woszczek G., Ptasinska A., Kowalski M.L., Wu T., Shelhamer J.H. Cytosolic phospholipase A2 Group IValpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells. J. Biol. Chem. 2004, 279:48550-48561.
34. Pontsler A.V., St Hilaire A., Marathe G.K., Zimmerman G.A., McIntyre T.M. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein. J. Biol. Chem. 2002, 277:13029-13036.
35. Shin H.M., Vieira V.M., Ryan P.B., Steenland K., Bartell S.M. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ. Health Perspect. 2011, 119:1760-1765.
36. Son H.Y., Kim S.H., Shin H.I., Bae H.I., Yang J.H. Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice. Arch. Toxicol. 2008, 82:239-246.
37. Son H.Y., Lee S., Tak E.N., Cho H.S., Shin H.I., Kim S.H., Yang J.H. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice. Environ. Toxicol. 2009, 24:580-588.
38. Stack J.H., Beaumont K., Larsen P.D., Straley K.S., Henkel G.W., Randle J.C., Hoffman H.M. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J. Immunol. 2005, 175:2630-2634.
39. Stock J.L., Shinjo K., Burkhardt J., Roach M., Taniguchi K., Ishikawa T., Kim H.S., Flannery P.J., Coffman T.M., McNeish J.D., Audoly L.P. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J. Clin. Invest. 2001, 107:325-331.
40. 2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur. J. Immunol. 2005, 35:460-468.
41. Thomas P.S. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 2001, 79:132-140.
42. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., Elliston O.K., Ayala J.M., Casano F.J., Chin J., Ding G.J.-F., Egger L.A., Gaffney E.P., Limjuco G., Palyha O.C., Raju S.M., Rolando A.M., Paul Salley J., Yamin T.-T., Lee T.D., Shively J.E., MacCross M., Mumford R.A., Schmidt J.A., Tocci M.J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356:768-774.